Home / Science / Hookworms: The Future of Immune Disorder Treatment?
Hookworms: The Future of Immune Disorder Treatment?
12 Sep
Summary
- Helminth therapy uses worm secretions to soothe immune responses.
- Large trials show mixed results for allergies and IBD.
- Researchers explore worm molecules for future drug development.

Helminth therapy, exploring the use of parasites like the human hookworm, is being investigated for its potential to alleviate symptoms of various immune and inflammatory conditions. Researchers have noted that these worms secrete molecules that can soothe the immune system, offering a potential therapeutic avenue. Early studies and anecdotal evidence suggested benefits for allergies, autoimmune diseases, and even osteoarthritis.
However, larger-scale clinical trials have produced inconclusive or mixed results regarding the efficacy of introducing live worms for conditions such as coeliac disease and inflammatory bowel disease. Some studies suggest that younger exposure to parasites might be more effective. Consequently, the scientific focus is shifting towards identifying and isolating specific proteins and molecules from the worms' secretions.
This new direction aims to develop targeted therapies derived from these naturally occurring compounds, potentially avoiding the risks associated with self-infection through an unregulated online black market. Researchers believe these molecules, evolved over millennia, hold the key to future treatments for immune disorders, offering a more controlled and potentially safer approach than whole-organism therapy.